Samsung Pharm Free Cash Flow Generation Index

Latest as of June 2022: 0.60x

Samsung Pharm free cash flow generation index. Samsung Pharm (001360) has a Free Cash Flow Generation Index of 0.60x as of June 2022. Free cash flow of ₩952.48 Million represents 1% of operating cash flow (₩1.59 Billion).

FCF Generation Index

0.60x

Free Cash Flow / Operating CF

Free Cash Flow

₩952.48 Million

KRW

Operating Cash Flow

₩1.59 Billion

KRW

Capital Expenditures

₩638.30 Million

KRW

Free Cash Flow Generation Index of Samsung Pharm (2017–2017)

Free cash flow generation index of Samsung Pharm from 2017 to 2017. Historical FCF Generation Index trend for Samsung Pharm across 1 annual periods. See Samsung Pharm (001360) flexibility index to measure the company's free cash flow as a share of total liabilities.

Samsung Pharm Free Cash Flow Generation Index by Year (2017–2017)

Samsung Pharm free cash flow generation index by year from 2017 to 2017. Year-by-year Free Cash Flow Generation Index for Samsung Pharm. For the full cash flow conversion analysis, see Samsung Pharm (001360) cash conversion ratio.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2017	-0.16x	₩-847.92 Million	₩5.15 Billion	₩6.11 Billion	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).